Key result
Chemoimmunotherapy was effective in inducing tumor regression in a 54-year-old man with primary cardiac lymphoma presenting with complete heart block, with remission maintained at 6 months.
Case Report (n=1)
Primary cardiac lymphoma is a rare but treatable cause of complete heart block in adults, highlighting the importance of multimodality imaging and tissue biopsy in atypical presentations.
Answers are grounded in this paper and cite their sources.
May inform rare cardiac lymphoma management with heart block; hypothesis-generating and leaves open need for larger studies.
Primary cardiac lymphoma (PCL) is a rare primary cardiac neoplasm with a relatively poor prognosis despite confinement to the heart and/or pericardium. We report a 54-year-old man who had presented with complete heart block for which he had undergone permanent pacemaker implantation, and six months later he was referred to us for evaluation of progressive exertional dyspnea. Multislice spiral computed tomography angiography of the heart and major vasculature showed infiltrative tumoral lesion that has involved interatrial septum, right atrium, left atrium, and left ventricle with invasion into the pulmonary artery. Tissue samples were taken using uniportal video-assisted thoracoscopic surgery, and the histologic examination revealed diffuse large B-cell lymphoma. Chemoimmunotherapy was effective in inducing tumor regression and the patient was still in remission during the next six months after treatment.
No takes yet. Share an insight, caveat, or question.
Amin et al. (2021) conducted a case report in Primary cardiac lymphoma (n=1). Chemoimmunotherapy was evaluated on Tumor regression and remission. Chemoimmunotherapy was effective in inducing tumor regression in a 54-year-old man with primary cardiac lymphoma presenting with complete heart block, with remission maintained at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: